Public Views on Managing Benign Prostatic Hyperplasia-Related Voiding Dysfunction: Potential Applications of Digital Therapeutic
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study aims to explore the potential of digital therapeutics in managing voiding dysfunction associated with benign prostatic hyperplasia (BPH). To achieve this, we collected and analyzed news and community data from major Korean platforms to assess the trends in media and community discussions and examine how digital therapeutics can contribute to personalized care and support self-management for patients with BPH-related voiding dysfunction. Methods: Data was collected over a 3-year period from October 2021 to September 2024 using the keywords ‘prostate,’ ‘urinary,’ and ‘treatment.’ Key terms and patterns were then identified through word frequency analysis, TF-IDF (term frequency-inverse document frequency) analysis, and N-gram analysis to examine the potential applicability of digital therapeutics in this area. Results: The news data primarily focused on expert-oriented medical information related to the treatment, surgical options, and diagnosis of BPH. In contrast, community data centered on discussions about everyday symptoms and solutions, such as urinary issues and self-care tips. This suggests that patients are particularly interested in practical problem-solving and selfmanagement strategies. Conclusions: This study suggests that digital therapeutics can empower patients with BPH to self-manage their urinary disorders through personalized management tools. Future research can be done to focus on empirically examining the clinical validity and practical applicability of digital therapeutics for BPH through clinical trials.
Abstract
Purpose: This study aims to explore the potential of digital therapeutics in managing voiding dysfunction associated with benign prostatic hyperplasia (BPH). To achieve this, we collected and analyzed news and community data from major Korean platforms to assess the trends in media and community discussions and examine how digital therapeutics can contribute to personalized care and support self-management for patients with BPH-related voiding dysfunction. Methods: Data was collected over a 3-year period from October 2021 to September 2024 using the keywords ‘prostate,’ ‘urinary,’ and ‘treatment.’ Key terms and patterns were then identified through word frequency analysis, TF-IDF (term frequency-inverse document frequency) analysis, and N-gram analysis to examine the potential applicability of digital therapeutics in this area. Results: The news data primarily focused on expert-oriented medical information related to the treatment, surgical options, and diagnosis of BPH. In contrast, community data centered on discussions about everyday symptoms and solutions, such as urinary issues and self-care tips. This suggests that patients are particularly interested in practical problem-solving and selfmanagement strategies. Conclusions: This study suggests that digital therapeutics can empower patients with BPH to self-manage their urinary disorders through personalized management tools. Future research can be done to focus on empirically examining the clinical validity and practical applicability of digital therapeutics for BPH through clinical trials.
참고문헌 (22)
- Yang M, "Influence of androgen receptor antagonist MDV3100 therapy on rats with benign prostatic hyperplasia", Int Neurourol J, 25, pp.219~228 (2021)
- Kim EJ, "The metaverse for healthcare : trends, applications, and future directions of digital therapeutics for urology", Int Neurourol J, 27(Suppl 1), pp.S3~S12 (2023)
- Jung JB, "Emerging market dynamics : exploring the convergence of human psychology and digital technology in Mindtech Services", J Digit Media Cult Technol, 4, pp.13~26 (2024)
- "Launched a mobile app to check for BPH by urine sounds. Medical Tribune" (2020)[URL]
- "Annual increase of 6.7% in patients with voiding dysfunction…60% are aged 60 and older" (2023)[URL]
- Eun SJ, "Development of personalized urination recognition technology using smart bands", Int Neurourol J, 21(Suppl 1), pp.S76~S83 (2017)
- de Britto LCV, "Benign prostatic hyperplasia and the urinary tract repercussions", Braz J Health Rev, 6, pp.23019~23028 (2023)
- Ko IG, "Add-on therapy with the α-blockers tamsulosin and naftopidil improves voiding function by enhancing neuronal activity in prostatic hyperplasia rats", Int Neurourol J, 22, pp.20~29 (2018)
- Sarma AV, "Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms", N Engl J Med, 367, pp.248~257 (2012)
- Savvides E, "Editorial for special issue : "current and emerging therapies for lower urinary tract symptoms and benign prostatic hyperplasia"", J Clin Med, 13, pp.2453~ (2024)
- McConnell JD, "The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia", N Engl J Med, 349, pp.2387~2398 (2003)
- La Torre A, "Sexual dysfunctions related to drugs used in the management of lower urinary tract symptoms due to benign prostatic hyperplasia : a narrative review on-blockers and 5-alpha reductase inhibitors", Uro, 1, pp.82~98 (2021)
- Yu J, "Comparison of efficacy of different surgical techniques for benign prostatic obstruction", Int Neurourol J, 25, pp.252~262 (2021)
- "Digital technologies connecting doctors and patients, a new clinical paradigm... ‘Allround Doctors’ developing digital therapeutics" (2022)[URL]
- "If you frequently feel the urge to urinate, ‘app-based therapy’ may be helpful" (2024)[URL]
- "How far has next-gen digital therapy come… overcoming incurable diseases with electronic medicine" (2021)[URL]
- "Medithings secures bridge funding from Kakao ventures and others" (2023)[URL]
- Cui L, "Status and issue analysis on indie game in China through CONCOR Analysis", J Digit Art Eng Multimedia, 10, pp.61~70 (2023)
- Song HJ, "A study on social perception of old downtown and landscape using big data analysis", J Next Gener Converg Inf Serv Technol, 13, pp.139~148 (2024)
- Welén K, "Androgens, aging, and prostate health", Rev Endocr Metab Disord, 23, pp.1221~1231 (2022)
- Clark RV, "Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alphareductase inhibitor", J Clin Endocrinol Metab, 89, pp.2179~2184 (2004)
- Kang EJ, "A trend analysis of Korean contemporary poetry research using topic modeling and N-gram analysis : focusing on WOS and SCOPUS DB from 2010 to 2023", J Korean Cult, 61, pp.169~201 (2023)